NEXT Severe Cold, Flu and Sore Throate Night Max Strength is a Oral Solution in the Human Otc Drug category. It is labeled and distributed by Genomma Lab Usa Inc. The primary component is Acetaminophen; Dextromethorphan Hydrobromide; Doxylamine Succinate; Phenylephrine Hydrochloride.
| Product ID | 50066-926_891fe403-1268-48c2-8933-d1d4a0bdf2bd |
| NDC | 50066-926 |
| Product Type | Human Otc Drug |
| Proprietary Name | NEXT Severe Cold, Flu and Sore Throate Night Max Strength |
| Generic Name | Acetaminophen, Dextromethorphan Hbr, Doxylamine Succinate, And Phenylephrine Hcl |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-06-21 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Genomma Lab USA Inc |
| Substance Name | ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE |
| Active Ingredient Strength | 650 mg/30mL; mg/30mL; mg/30mL; mg/30mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |